BSX•benzinga•
Truist Securities Maintains Buy on Boston Scientific, Raises Price Target to $117
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 24, 2025 by benzinga